GoodRx Holdings (GDRX) Net Cash Flow Growth (3y) (2022 - 2026)

GoodRx Holdings (GDRX) Net Cash Flow Growth (3y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 31.95%
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn -1,545.42%
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn -23.22%
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 50.05%
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -28.47%
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 GoodRx Holdings 1.27 Bn 972.56 Mn 179.41 Mn 304.45%

Historic Data

Download Data
DateValue
Jun 30, 2026 304.45%
Mar 31, 2026 -105.50%
Dec 31, 2025 -34.12%
Sep 30, 2025 -64.37%
Jun 30, 2025 44.48%
Mar 31, 2025 -15.48%
Dec 31, 2024 -5.47%
Sep 30, 2024 -98.65%
Jun 30, 2024 56.02%
Mar 31, 2024 -103.15%
Dec 31, 2023 -4.86%
Sep 30, 2023 -67.41%
Jun 30, 2023 -69.05%
Mar 31, 2023 -61.74%
Dec 31, 2022 41.68%